创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

LIU Xiaoyue, YU Ziheng, WANG Xinren, TANG Weifang, LU Tao. Research Progress in Cyclin-dependent Kinase 12 Inhibitors[J]. Progress in Pharmaceutical Sciences, 2022, 46(3): 208-217.
Citation: LIU Xiaoyue, YU Ziheng, WANG Xinren, TANG Weifang, LU Tao. Research Progress in Cyclin-dependent Kinase 12 Inhibitors[J]. Progress in Pharmaceutical Sciences, 2022, 46(3): 208-217.

Research Progress in Cyclin-dependent Kinase 12 Inhibitors

  • Cyclin-dependent kinase (CDK) plays an important role in cell cycle regulation and gene transcription. CDK12 can participate in gene transcription regulation by regulating gene transcription extension, RNA splicing, transcription termination and DNA damage repair (DDR). It is found that the dysregulation of CDK12 is related to the tumorigenesis and tumor metastasis. This article introduces the structure and biological functions of CDK12 as well as its relationship with tumors, and reviews the research progress in CDK12 inhibitors, aiming to provide reference for further research on the mechanism of CDK12 and the development in CDK12 inhibitors.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return